% | $
Quotes you view appear here for quick access.

Ironwood Pharmaceuticals, Inc. Message Board

  • balram79 balram79 Jul 16, 2012 10:38 PM Flag

    undervalued !!!!!!!!!!!

    Looking at the 4 ph3 studies,

    * all the primary and secondary endpoints met efficacy (good sign for a label) and
    * no advisory committee which translates to no major safety concerns (risk benefit)

    If peak sales projected in US alone are ~ 3 billions and with royalties from ROW in place, this is arguably one of the most undervalued "no brainer" stock going into the PDUFA date.

    BUY !!!!!!!!!

13.50-0.47(-3.36%)Aug 24 4:00 PMEDT